Skip to main content
. Author manuscript; available in PMC: 2021 Mar 23.
Published in final edited form as: Leukemia. 2020 Feb 24;34(9):2375–2383. doi: 10.1038/s41375-020-0775-3

Fig. 5. Intra-BM transfusion of MSC-reprogrammed macrophages largely rescues the therapeutic effects of MSC-treatment in leukemic mice.

Fig. 5

a Schematic diagram of MSC-reprogrammed macrophages transfusion strategy. b Representative dot plots of platelet populations and quantitative gating. c Kinetic analysis of platelets in PB of leukemia-bearing mice treated with PBS or E-Mac (n = 6). d Flow cytometry analysis of MSCs in leukemia-bearing mice post PBS/E-Mac treatment. e Statistical analysis of the absolute numbers of host MSCs in tibias from PBS/E-Mac treated leukemic mice (mean ± SD, n = 6). Asterisk indicates ***p < 0.001 (unpaired student’s t-test (two-tailed)).